UK MHRA Gives Nod to Winlevi for Acne
The Medicines and Healthcare products Regulatory Agency (MHRA) has approved clascoterone cream 1% (Winlevi, Cosmo and Glenmark) for acne vulgaris in patients aged 12 years and older in the UK. Clascoterone cream 1% is the first commercially available topical androgen receptor inhibitor. This approach is believed to help reduce sebum production and intervene early in […]